Skip to main content
Medplus Health Services Limited logo

Medplus Health Services Limited — Investor Relations & Filings

Ticker · MEDPLUS ISIN · INE804L01022 LEI · 335800QYF5P4YJGT4P11 BSE.NS Wholesale and retail trade
Open in API
Filings indexed 776 across all filing types
Latest filing 2026-05-25 Regulatory Filings
Country IN India
Listing BSE.NS MEDPLUS

About Medplus Health Services Limited

https://www.medplusindia.com

Medplus Health Services Limited is an omnichannel retail pharmacy chain that operates an extensive network of physical stores alongside an integrated digital platform. The company specializes in the distribution and sale of pharmaceutical products, medical devices, and wellness goods. Its service portfolio extends to diagnostic testing through specialized laboratory divisions and the provision of optical products. By utilizing a technology-driven supply chain and a hub-and-spoke distribution model, the organization manages inventory and ensures the availability of authentic healthcare products. The company focuses on delivering a comprehensive range of prescription and over-the-counter medications, personal care items, and nutritional supplements through both its retail outlets and online marketplace.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 87% confidence The document is a compliance declaration filed under SEBI SAST Regulations stating the promoter has not encumbered shares. It is a routine regulatory compliance announcement rather than a financial report, earnings release, or share acquisition notice. It does not report financial results or changes in capital. It therefore falls under the generic Regulatory Filings category (RNS).
2026-05-25 English
Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 82% confidence The document is an exchange filing under SEBI (Listing Obligations and Disclosure Requirements) Regulation 30, notifying stock exchanges of a subsidiary’s drug license suspension orders and quantifiable impact. It contains no financial statements, no meeting materials, and no detailed report itself—rather it’s a regulatory/compliance announcement. This does not fit into specific types like 10-K, IR, ER, or LTR (legal proceedings is for lawsuits/regulatory actions of a different nature). It best matches the general Regulatory Filings category (RNS).
2026-05-23 English
General Updates
Regulatory Filings Classification · 82% confidence The document is a compliance update submitted under SEBI (Listing Obligations and Disclosure Requirements) Regulation 30 to the BSE and NSE, informing about suspension orders received by a subsidiary. It is a regulatory announcement of a material event rather than a standalone financial report, management discussion, or other defined category. Therefore, it falls under general regulatory filings.
2026-05-23 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 92% confidence The document is a letter addressed to the stock exchanges under SEBI LODR, stating that the Board has approved audited financial results and that extracts have been published in newspapers (newspaper clippings attached) and made available on the company website. It does not itself contain the full financial statements but announces the publication of those results. This matches the definition of a Report Publication Announcement (RPA).
2026-05-22 English
Submission of Newspaper Clippings
Report Publication Announcement Classification · 87% confidence The document is a letter to stock exchanges notifying them that the Board has approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and that extracts have been published in newspapers (with clippings attached). It does not contain the full financial statements but is an announcement of the publication of the report. Under the “menu vs meal” rule, this is a Report Publication Announcement rather than the report itself.
2026-05-22 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 85% confidence The document is a compliance declaration under Regulation 31(4) of SEBI (SAST) Regulations, submitted to stock exchanges stating that the promoter has not encumbered shares. It is a regulatory announcement without any financial statements, falling under miscellaneous regulatory disclosures. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-05-22 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.